Aware of the strong potential of its platform in many therapeutic areas (Inflammation, Metabolism, CardioVascular…), CarboMimetics is already considering strategic research collaborations outside Oncology.

 

Therefore, any organization interested to evaluate this type of collaboration is more than welcome to contact us.